Can ramelteon decrease the tic of Tourette's syndrome

Phase 3

Recruiting

• Conditions: Tourett's syndrome; Tourett, tic, ramelteon, melatonin; D005879

• Registration Number: JPRN-jRCTs021190012
• Lead Sponsor: SUGAWARA Masashiro

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-11-26
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

1) 18-30 years of age.
2) Patient who fills the diagnostic criteria of Tourette's disorder according to the DSM-5.
3) Patient who can declare the one's written agreement to participate in the study.

Exclusion Criteria

1) Having a history of other neurological and psychiatric disorders that can affect the motor and psychological function.
2) Having a distinct focal lesion on the brain MRI.
3) Patient who had change in the treatment within 4 weeks prior to the registration.
4) Patient who had been medicated ramelteon in the past.
5) Having liver dysfunction.
6) Having severe sleep apnea syndrome.
7) Taking an administration of fluvoxamine maleate.

Study & Design

• Study Type: Interventional
• Study Design: Not specified